+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033- Product Image
Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033- Product Image
New

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Grand View Research
  • ID: 5748251
Description Jump to:

Onychomycosis Market Growth & Trends

The global onychomycosis market size is anticipated to reach USD 5.74 billion by 2033. The market is projected to grow at a CAGR of 4.7% from 2025 to 2033. The growth of the onychomycosis market is attributable to the increasing incidence of onychomycosis and chronic diseases aided by rising awareness about treatment. The infection leads to psychological and social limitations which can limit an individual's ability to work and socialize which makes it important to provide effective and efficient treatment for patients suffering from the infection further propelling the market growth.

Rising rate of onychomycosis is the key factor contributing to the overall growth of the market. The infection, often known as toenail fungus or fungal nail infection, affects over 14% of the total population in the U.S. However, most people are unaware of how harmful toenail fungus is, despite it is extremely contagious in nature and increasing the risk of developing with age.

International organizations such as the Global Nail Fungus Organization are working with public health officials and healthcare professionals worldwide to increase awareness and improve the prevention and treatment of nail fungus across the globe. This is anticipated to propel the demand for therapeutics. Government initiatives such as Think Fungus by the Centers for Disease Control and Prevention (CDC), emphasize the significance of detecting fungal diseases such as onychomycosis, early enough in the course of a patient's condition to ensure the administration of relevant therapy. This is inducing a surge in demand for onychomycosis therapeutics and is expected to drive market growth in the country.

Furthermore, the key players are focusing on collaborations and partnerships to develop novel onychomycosis therapies and to maintain their competitive position in the market. For instance, in August 2022, Moberg Pharma AB entered into a distribution agreement with Padagis Israel Agencies Ltd. that is expected to give Padagis exclusive rights for selling and marketing MOB-015, a treatment for onychomycosis in Israel. Moreover, innovations to address the concerns such as improving patient compliance and reducing the dosage are expected to fuel the market growth. For instance, in October 2021, Intas Pharmaceuticals launched SB 100mg under the brand name Itaspor-SB Forte/Subawin which is the world's first Super Bioavailable Itraconazole. This initiative is expected to significantly increase patient compliance and reduce the cost of therapy.

Onychomycosis Market Report Highlights

  • Distal subungual onychomycosis segment dominated the market in 2024 and is attributable to the increasing prevalence and number of generic approvals by the FDA to meet the rising demands
  • Topical segment is expected to show the fastest growth rate over the forecast period owing to ease of usage and administration which leads to increased patient compliance with treatment
  • Players have an increased focus on acquiring specialized capacities that are highly capital-intensive to develop and maintain their competitive position
  • North America held the largest market share in 2024 which can be attributed to better access to healthcare, the presence of a wide target population, and high adoption of treatment

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Treatment
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Onychomycosis Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Onychomycosis Market: Type Business Analysis
4.1. Type Market Share, 2025 & 2033
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Distal Subungual Onychomycosis
4.4.1. Distal Subungual Onychomycosis Market, 2021 - 2033 (USD Million)
4.5. White Superficial Onychomycosis
4.5.1. White Superficial Onychomycosis Market, 2021 - 2033 (USD Million)
4.6. Proximal Subungual Onychomycosis
4.6.1. Proximal Subungual Onychomycosis Market, 2021 - 2033 (USD Million)
4.7. Other Types
4.7.1. Other Types Market, 2021 - 2033 (USD Million)
Chapter 5. Onychomycosis Market: Treatment Business Analysis
5.1. Treatment Market Share, 2025 & 2033
5.2. Treatment Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
5.4. Oral
5.4.1. Oral Market, 2021 - 2033 (USD Million)
5.5. Topical
5.5.1. Topical Market, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Onychomycosis Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Onychomycosis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Europe Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Onychomycosis Market Estimates and Forecasts, 2017 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Bausch Health Companies Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. GSK plc
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Abbott
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Pfizer Inc
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Bayer AG
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Teva Pharmaceutical Industries Ltd.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Cipla
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Merck & Co., Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Novartis AG
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Sun Pharmaceutical Industries Ltd.
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global onychomycosis market, by region, 2021 - 2033 (USD Million)
Table 4 Global onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 5 Global onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 6 North America onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 7 North America onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 8 North America onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 9 U.S. onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 10 U.S. onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 11 Canada onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 12 Canada onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 13 Mexico onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 14 Mexico onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 15 Europe onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 16 Europe onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 17 Europe onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 18 UK onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 19 UK onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 20 Germany onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 21 Germany onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 22 France onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 23 France onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 24 Italy onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 25 Italy onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 26 Spain onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 27 Spain onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 28 Norway onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 29 Norway onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 30 Denmark onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 31 Denmark onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 32 Sweden onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 33 Sweden onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 34 Asia Pacific onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 35 Asia Pacific onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 36 Asia Pacific onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 37 Japan onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 38 Japan onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 39 China onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 40 China onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 41 India onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 42 India onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 43 Australia onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 44 Australia onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 45 South Korea onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 46 South Korea onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 47 Thailand onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 48 Thailand onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 49 Latin America onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 50 Latin America onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 51 Latin America onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 52 Brazil onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 53 Brazil onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 54 Argentina onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 55 Argentina onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 56 Middle East & Africa Onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 58 Middle East & Africa onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 59 South Africa onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 60 South Africa onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 62 Saudi Arabia onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 63 UAE onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 64 UAE onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 65 Kuwait onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 66 Kuwait onychomycosis market, by treatment, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Onychomycosis market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and application outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Onychomycosis market dynamics
Fig. 12 Onychomycosis market: Porter’s five forces analysis
Fig. 13 Onychomycosis market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Million)
Fig. 15 Distal Subungual Onychomycosis market, 2021 - 2033 (USD Million)
Fig. 16 White Superficial Onychomycosis market, 2021 - 2033 (USD Million)
Fig. 17 Proximal Subungual Onychomycosis market, 2021 - 2033 (USD Million)
Fig. 18 Other Types market, 2021 - 2033 (USD Million)
Fig. 19 Treatment market, 2021 - 2033 (USD Million)
Fig. 20 Oral market, 2021 - 2033 (USD Million)
Fig. 21 Topical market, 2021 - 2033 (USD Million)
Fig. 22 Others market, 2021 - 2033 (USD Million)
Fig. 23 Onychomycosis market revenue, by region
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 North America onychomycosis market, 2021 - 2033 (USD Million)
Fig. 26 U.S. country dynamics
Fig. 27 U.S. onychomycosis market, 2021 - 2033 (USD Million)
Fig. 28 Canada country dynamics
Fig. 29 Canada onychomycosis market, 2021 - 2033 (USD Million)
Fig. 30 Mexico country dynamics
Fig. 31 Mexico onychomycosis market, 2021 - 2033 (USD Million)
Fig. 32 Europe onychomycosis market, 2021 - 2033 (USD Million)
Fig. 33 UK country dynamics
Fig. 34 UK onychomycosis market, 2021 - 2033 (USD Million)
Fig. 35 Germany country dynamics
Fig. 36 Germany onychomycosis market, 2021 - 2033 (USD Million)
Fig. 37 France country dynamics
Fig. 38 France onychomycosis market, 2021 - 2033 (USD Million)
Fig. 39 Italy country dynamics
Fig. 40 Italy onychomycosis market, 2021 - 2033 (USD Million)
Fig. 41 Spain country dynamics
Fig. 42 Spain onychomycosis market, 2021 - 2033 (USD Million)
Fig. 43 Norway country dynamics
Fig. 44 Norway onychomycosis market, 2021 - 2033 (USD Million)
Fig. 45 Sweden country dynamics
Fig. 46 Sweden onychomycosis market, 2021 - 2033 (USD Million)
Fig. 47 Denmark country dynamics
Fig. 48 Denmark onychomycosis market, 2021 - 2033 (USD Million)
Fig. 49 Asia Pacific onychomycosis market, 2021 - 2033 (USD Million)
Fig. 50 Japan country dynamics
Fig. 51 Japan onychomycosis market, 2021 - 2033 (USD Million)
Fig. 52 China country dynamics
Fig. 53 China onychomycosis market, 2021 - 2033 (USD Million)
Fig. 54 India country dynamics
Fig. 55 India onychomycosis market, 2021 - 2033 (USD Million)
Fig. 56 Australia country dynamics
Fig. 57 Australia onychomycosis market, 2021 - 2033 (USD Million)
Fig. 58 South Korea country dynamics
Fig. 59 South Korea onychomycosis market, 2021 - 2033 (USD Million)
Fig. 60 Thailand country dynamics
Fig. 61 Thailand onychomycosis market, 2021 - 2033 (USD Million)
Fig. 62 Latin America onychomycosis market, 2021 - 2033 (USD Million)
Fig. 63 Brazil country dynamics
Fig. 64 Brazil onychomycosis market, 2021 - 2033 (USD Million)
Fig. 65 Argentina country dynamics
Fig. 66 Argentina onychomycosis market, 2021 - 2033 (USD Million)
Fig. 67 MEA onychomycosis market, 2021 - 2033 (USD Million)
Fig. 68 South Africa country dynamics
Fig. 69 South Africa onychomycosis market, 2021 - 2033 (USD Million)
Fig. 70 Saudi Arabia country dynamics
Fig. 71 Saudi Arabia onychomycosis market, 2021 - 2033 (USD Million)
Fig. 72 UAE country dynamics
Fig. 73 UAE onychomycosis market, 2021 - 2033 (USD Million)
Fig. 74 Kuwait country dynamics
Fig. 75 Kuwait onychomycosis market, 2021 - 2033 (USD Million)
Fig. 76 Company categorization
Fig. 77 Company market position analysis
Fig. 78 Strategic framework

Companies Mentioned

  • Bausch Health Companies Inc.
  • GSK plc
  • Abbott
  • Pfizer Inc
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Cipla
  • Merck & Co., Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages150
PublishedJune 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 3.81 Billion
Forecasted Market Value ( USD ) by 2033 $ 5.74 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Onychomycosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Onychomycosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 178 Pages
  • Global
From
Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033 - Product Image

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Onychomycosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 126 Pages
  • Global
From
Onychomycosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Onychomycosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 170 Pages
  • Global
From
Onychomycosis Market Report 2025 - Product Image

Onychomycosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.